Ivabradine for Rate Control in Permanent Atrial Fibrillation
common.study.values.description
“Ivabradine for Rate Control in Permanent Atrial Fibrillation”
Ivabradine may be useful as a rate controlling agent in atrial fibrillation without negative effects on hemodynamics and inotropy. The objective in this proof of concept study is to investigate the hypothesis that ivabradine will slow the ventricular response in patients with permanent atrial fibrillation and previously-implanted pacemakers.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Ivabradine
Ivabradine will be started and titrated to heart rate slowing of 20 bpm or greater, or an increase in pacing.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Ivabradine for Rate Control in Permanent Atrial Fibrillation
common.study.values.clinical-trial-id
NCT03987204
participant.views.study.view.id
eXD9ge
